Given its established role in cholestasis and liver cancer, SALL4 may provide therapeutic potential whereas its context-dependent effects necessitate a precise approach with caution such as complete inhibition of SALL4 could prevent malignant transformation but may also impair normal liver regeneration. The gene discussed is SALL4; the disease is liver cancer.